Ironwood Pharmaceuticals, Inc. (IRWD)
$3.59-4.52%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $591M
- Beta
- 0.22
- P/E (TTM)
- 4.51
- Short % float
- 9.81%
- Days to cover
- 6.2
- SI change
- -16.9%
- 1W
- -1.10%
- 1M
- -13.91%
- vs SPY 1W
- -0.96%
- vs SPY 1M
- -16.41%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IRWD?
- LOPJLB’s latest quantitative signal on Ironwood Pharmaceuticals, Inc. (IRWD) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IRWD in?
- Ironwood Pharmaceuticals, Inc. (IRWD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Ironwood Pharmaceuticals, Inc. (IRWD) do?
- Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or…